<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364110">
  <stage>Registered</stage>
  <submitdate>22/04/2013</submitdate>
  <approvaldate>3/05/2013</approvaldate>
  <actrnumber>ACTRN12613000495729</actrnumber>
  <trial_identification>
    <studytitle>Dexmeditomedine for mitral valve replacement  </studytitle>
    <scientifictitle>dexmeditomedine for heart rate control during mitral valve replacement for mitral stenosis a randomised controlled double blind study
</scientifictitle>
    <utrn>nil</utrn>
    <trialacronym />
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>patients with tight mitral stenosis scheduled for mitral valve replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>70 patients scheduled for mitral valve replacement divided equally into two groups were studied in this randomized controlled double blind study ; Group D : received (after induction of anesthesia) dexmeditomedine 1ug/kg bolus dose over 10 minutes followed by an infusion of 0.5 ug/kg/h till the start of cardiopulmonary bypass. Group F: received saline bolus ( after induction of anesthesia ) and infusion of saline till the start of cardiopulmonary bypass instead of dexmeditomedine .Anesthetic management for both groups was the same. </interventions>
    <comparator>we compared the effect of dexmeditomedine bolus and infusion  on the heart rate of patients with tight mitral stenosis compared to placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>heart rate changes as measured by pulse oximeter and ECG</outcome>
      <timepoint>the start of infusion following a bolus of dexmeditomedine after induction of anesthesia and every 10 minutes after the end of the bolus till the start of cardiopulmonary bypass</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>none</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>patients ASAI&amp;II with tight ( less than one centimeter ) mitral stenosis aged 18-60 years of age scheduled for mitral valve replacement</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>age above or below 18-60 years , mitral valve area more than one centimeter, renal or hepatic dysfunction , cardiac medications that affect heart rate </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>it is a computer generated allocation using graphpad software 
allocation was concealed using sealed envelopes </concealment>
    <sequence>we used a computer generated sequence</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>The Graph Pad Instat 3.0 was used  to estimate sample size of 33 cases for each group (completed to 35 cases) to be sufficient for 80 % power to detect a difference of 20 % in heart rate( a difference 0f 13.6 in mean heart rate between the two groups )  and  mean blood pressure (based on previously published data) under a 5% significance level ( graphPad software, San Deigo , CA, USA.)). Chi-square test was used for analysis of non-parametric data between the two groups  and Mc-Nemar test for analysis within each group. Unpaired t - test was used for analysis of parametric data between the two groups ,while paired-t-test test was used for analysis of parametric data  within each group,  data are expressed as mean+/- SD and P value less than 0.05 was considered statistically significant.    </statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>5/11/2011</anticipatedstartdate>
    <actualstartdate>5/11/2011</actualstartdate>
    <anticipatedenddate>2/05/2013</anticipatedenddate>
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Qena - upper Egypt</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>south valley university -Qena university hospital</primarysponsorname>
    <primarysponsoraddress>Qena university hospital -Qena - P.O. 61111- Qena </primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>south valley university - Egypt</fundingname>
      <fundingaddress>Egypt - Qena - South valley university - Qena faculty of medicine P.O. 6111 -Qena</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>testing the efficacy and safety of dexmeditomedine in controlling heart rate in patients with tight mitral stenosis subjected to mitral valve replacement during the prebypass period</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>salah mostafa asida </name>
      <address>South Valley University -Qena faculty of medicine - department of anesthesia - P.O. 61111- Qena- Egypt</address>
      <phone>+201005262075</phone>
      <fax />
      <email>salasida@hotmail.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>salah asida</name>
      <address>South Valley University - Qena faculty of medicine - department of anesthesia - P.O. 61111- Qena Egypt</address>
      <phone>+201005262075</phone>
      <fax />
      <email>salasida@hotmail.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>salah asida</name>
      <address>South Valley University- Qena faculty of medicine - department of anesthesia - P.O. 61111-  Qena- Egypt</address>
      <phone>+201005262075</phone>
      <fax />
      <email>salasida@hotmail.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>salah asida</name>
      <address>South Valley University- Qena faculty of medicine - department of anesthesia - P.O. 61111-  Qena- Egypt</address>
      <phone>+201005262075</phone>
      <fax />
      <email>salasida@hotmail.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>